RIM
CDLX icon

Ranger Investment Management’s Cardlytics CDLX Stock Holding History

Ranger Investment Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-29,977
Closed -$6.69M – 109
2022
Q2 		$6.69M Sell
29,977
-582
-2% -$195K 0.51% 54
2022
Q1 		$16.8M Buy
30,559
+796
+3% +$481K 1.06% 40
2021
Q4 		$19.7M Buy
29,763
+13,663
+85% +$10.4M 1.07% 40
2021
Q3 		$13.5M Sell
16,100
-412
-2% -$418K 0.72% 50
2021
Q2 		$21M Buy
+16,512
New +$18.6M 1.09% 43

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ranger Investment Management's CDLX Position: Q3 2022 in Review

Ranger Investment Management sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 29,977 shares — an estimated $6.69M sold.

Ranger Investment Management first reported a position in CDLX in Q2 2021 and held it in 5 quarters. The position peaked at $21M in Q2 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Ranger Investment Management reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Ranger Investment Management sold 29,977 Cardlytics shares in Q3 2022, an estimated $6.69M.
  • Ranger Investment Management first reported a position in Cardlytics in Q2 2021 and held it in 5 quarters.
  • Ranger Investment Management's Cardlytics position peaked at $21M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Ranger Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.